Added to YB: 2026-08-13
Pitch date: 2026-08-11
ALC.SW [neutral]
Alcon Inc.
-2.41%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care.
Market Cap
CHF 36.4B
Pitch Price
CHF 60.68
Price Target
N/A
Dividend
0.46%
EV/EBITDA
16.15
P/E
57.35
EV/Sales
3.70
Sector
Health Care Equipment and Supplies
Category
growth
Alcon (ALC Switzerland): New products push growth higher
ALC.SW (earnings): Q2 sales +8% to $2.78bn (7% cc), core op margin 20.6%. Surgical +8% on UNITY equipment (+26%), PanOptix Pro; Vision Care +8%, Ocular Health +13% on Tryptyr. Raised 2026 guide: 5-7% cc growth, 90-190bp margin exp, 12-15% EPS growth. Blemish: $563m adjustments, $402m PowerVision impairment cut reported income to $11m.
Read full article (2 min)